The future of biomanufacturing in Singapore

Singapore's vision is to become a global biomedical sciences (BMS) hub and to develop the BMS industry as the fourth manufacturing pillar of Singapore's economy. The biomanufacturing industry has been a significant growth area for Singapore's BMS industry, with four major biologics investments totaling close to US$1 billion being committed in less than 2 years and the setting up of local biomanufacturing companies. In parallel, resources in biomedical research and bioprocess manpower capabilities are being built up for this knowledge-intensive industry. Located at the Biopolis, the epicenter of biomedical R&D, the Bioprocessing Technology Institute (BTI) has been developing bioprocess expertise and programs to support the manpower needs of the growing biomanufacturing sector. With a strong commitment to provide the biomanufacturing industry with research and manpower support, the future looks promising and Singapore is well positioned to become a leading biomanufacturing hub in Asia Pacific.